[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Pharmashot PharmaShots | Iluminate.Innovate.Inspire PharmaShots | Iluminate.Innovate.Inspire posts on X about hologic inc, $4528t, #ai, bms the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1022473214457348096/interactions)  - X Week XXX -XXXX% - X Month XXXXX -XXXX% - X Months XXXXXX +110% - X Year XXXXXX +254% ### Mentions: X [#](/creator/twitter::1022473214457348096/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XXX +92% - X Year XXX +308% ### Followers: XXXXX [#](/creator/twitter::1022473214457348096/followers)  - X Week XXXXX -XXXX% - X Month XXXXX +0.22% - X Months XXXXX +1.70% - X Year XXXXX +0.35% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1022473214457348096/influencer_rank)  ### Social Influence [#](/creator/twitter::1022473214457348096/influence) --- **Social category influence** [stocks](/list/stocks) XXX% **Social topic influence** [hologic inc](/topic/hologic-inc) 1.72%, [$4528t](/topic/$4528t) 1.72%, [#ai](/topic/#ai) 1.72%, [bms](/topic/bms) 1.72%, [novo](/topic/novo) 1.72%, [$21b](/topic/$21b) 1.72%, [eli lilly](/topic/eli-lilly) 1.72%, [$8750t](/topic/$8750t) 1.72%, [$4568t](/topic/$4568t) 1.72%, [$6417t](/topic/$6417t) XXXX% **Top accounts mentioned or mentioned by** [@novonordisk](/creator/undefined) [@ubeindustries](/creator/undefined) [@angelinipharma](/creator/undefined) [@sanofi](/creator/undefined) [@zailabglobal](/creator/undefined) [@sunpharmalive](/creator/undefined) [@zailab_global](/creator/undefined) **Top assets mentioned** [Hologic, Inc. (HOLX)](/topic/hologic-inc) [Eli Lilly and Company (LLY)](/topic/eli-lilly) ### Top Social Posts [#](/creator/twitter::1022473214457348096/posts) --- Top posts by engagements in the last XX hours "Gedeon Richter Pharma GmbH and Hikma Pharmaceuticals Secure the US FDAs Approval for Enoby and Xtrenbo (Biosimilar Prolia & Xgeva) #biosimilar #enoby #xtrenbo #prolia #xgeva #denosumab #rgb14p #rgb14x #gedeonrichter #hikmapharmaceuticals #usfda #bla" [X Link](https://x.com/Pharmashot/status/1972640120798154937) [@Pharmashot](/creator/x/Pharmashot) 2025-09-29T12:30Z 2276 followers, XX engagements "Hologic Inc. Receives the US FDAs 510(k) Clearance & European CE Mark for Panther Fusion GI Bacterial Assays to Advance Gastroenteritis Diagnostics #hologic #pantherfusion #gibacterialassay #infectiousgastroenteritis #moleculardiagnostics" [X Link](https://x.com/Pharmashot/status/1974059974734004476) [@Pharmashot](/creator/x/Pharmashot) 2025-10-03T10:32Z 2276 followers, XX engagements "ONO PHARMACEUTICAL CO. LTD. Reveals the P-II (ONO-4578-08) Trial Findings of ONO-4578 in Gastric or Gastroesophageal Junction Cancer #ono #pii #ono457808 #ono4578 #ep4antagonist #gastriccancer #gastroesophagealjunctioncancer #opdivo #clinicaltrial" [X Link](https://x.com/Pharmashot/status/1976616134733668856) [@Pharmashot](/creator/x/Pharmashot) 2025-10-10T11:49Z 2276 followers, XX engagements "insitro and Bristol Myers Squibb Collaborate to Advance Drug Discovery for Amyotrophic Lateral Sclerosis #insitro #bms #collaboration #ai #amyotrophiclateralsclerosis #chemml #drugdiscovery #pharma #smallmolecule #machinelearning" [X Link](https://x.com/Pharmashot/status/1978423871230398864) [@Pharmashot](/creator/x/Pharmashot) 2025-10-15T11:33Z 2276 followers, XX engagements "Novo Nordisk Signs $2.1B Deal with Omeros Corporation to Advance Zaltenibart for Rare Blood & Kidney Disorders #novonordisk #omeros #zaltenibart #oms906 #piii #paroxysmalnocturnalhemoglobinuria #masp3inhibitor #kidneydisorders #licensingdeal #pharma" [X Link](https://x.com/Pharmashot/status/1978729218017034473) [@Pharmashot](/creator/x/Pharmashot) 2025-10-16T07:46Z 2278 followers, XX engagements "Eli Lilly and Company Reveals Topline Data from P-III (ACHIEVE-2 & 5) Trials of Orforglipron for Type X Diabetes #elililly #piii #achieve2 #achieve5 #orforglipron #type2diabetes #achieve4 #owl833 #ly3502970 #obesity #clinicaltrial" [X Link](https://x.com/Pharmashot/status/1978772085397729477) [@Pharmashot](/creator/x/Pharmashot) 2025-10-16T10:36Z 2276 followers, XX engagements "Regeneron Receives CHMPs Positive Opinion for Adjuvant Libtayo to Treat High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) #regeneron #libtayo #cpost #cutaneoussquamouscellcarcinoma #cemiplimab #piii #thenejm #ema #chmp #regulatory #regn2810 #sar439684" [X Link](https://x.com/Pharmashot/status/1980523502227890193) [@Pharmashot](/creator/x/Pharmashot) 2025-10-21T06:36Z 2278 followers, XX engagements "Daiichi Sankyo and MSD Report the P-II Study Data for Raludotatug Deruxtecan in Pt.-Resistant Ovarian Cancer #daiichisankyo #merckco #raludotatugderuxtecan #rdxd #ovariancancer #cdh6 #adc #rejoiceovarian01 #btd #esmo2025 #mk3475" [X Link](https://x.com/Pharmashot/status/1980537965458989311) [@Pharmashot](/creator/x/Pharmashot) 2025-10-21T07:33Z 2278 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PharmaShots | Iluminate.Innovate.Inspire posts on X about hologic inc, $4528t, #ai, bms the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXX%
Social topic influence hologic inc 1.72%, $4528t 1.72%, #ai 1.72%, bms 1.72%, novo 1.72%, $21b 1.72%, eli lilly 1.72%, $8750t 1.72%, $4568t 1.72%, $6417t XXXX%
Top accounts mentioned or mentioned by @novonordisk @ubeindustries @angelinipharma @sanofi @zailabglobal @sunpharmalive @zailab_global
Top assets mentioned Hologic, Inc. (HOLX) Eli Lilly and Company (LLY)
Top posts by engagements in the last XX hours
"Gedeon Richter Pharma GmbH and Hikma Pharmaceuticals Secure the US FDAs Approval for Enoby and Xtrenbo (Biosimilar Prolia & Xgeva) #biosimilar #enoby #xtrenbo #prolia #xgeva #denosumab #rgb14p #rgb14x #gedeonrichter #hikmapharmaceuticals #usfda #bla"
X Link @Pharmashot 2025-09-29T12:30Z 2276 followers, XX engagements
"Hologic Inc. Receives the US FDAs 510(k) Clearance & European CE Mark for Panther Fusion GI Bacterial Assays to Advance Gastroenteritis Diagnostics #hologic #pantherfusion #gibacterialassay #infectiousgastroenteritis #moleculardiagnostics"
X Link @Pharmashot 2025-10-03T10:32Z 2276 followers, XX engagements
"ONO PHARMACEUTICAL CO. LTD. Reveals the P-II (ONO-4578-08) Trial Findings of ONO-4578 in Gastric or Gastroesophageal Junction Cancer #ono #pii #ono457808 #ono4578 #ep4antagonist #gastriccancer #gastroesophagealjunctioncancer #opdivo #clinicaltrial"
X Link @Pharmashot 2025-10-10T11:49Z 2276 followers, XX engagements
"insitro and Bristol Myers Squibb Collaborate to Advance Drug Discovery for Amyotrophic Lateral Sclerosis #insitro #bms #collaboration #ai #amyotrophiclateralsclerosis #chemml #drugdiscovery #pharma #smallmolecule #machinelearning"
X Link @Pharmashot 2025-10-15T11:33Z 2276 followers, XX engagements
"Novo Nordisk Signs $2.1B Deal with Omeros Corporation to Advance Zaltenibart for Rare Blood & Kidney Disorders #novonordisk #omeros #zaltenibart #oms906 #piii #paroxysmalnocturnalhemoglobinuria #masp3inhibitor #kidneydisorders #licensingdeal #pharma"
X Link @Pharmashot 2025-10-16T07:46Z 2278 followers, XX engagements
"Eli Lilly and Company Reveals Topline Data from P-III (ACHIEVE-2 & 5) Trials of Orforglipron for Type X Diabetes #elililly #piii #achieve2 #achieve5 #orforglipron #type2diabetes #achieve4 #owl833 #ly3502970 #obesity #clinicaltrial"
X Link @Pharmashot 2025-10-16T10:36Z 2276 followers, XX engagements
"Regeneron Receives CHMPs Positive Opinion for Adjuvant Libtayo to Treat High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) #regeneron #libtayo #cpost #cutaneoussquamouscellcarcinoma #cemiplimab #piii #thenejm #ema #chmp #regulatory #regn2810 #sar439684"
X Link @Pharmashot 2025-10-21T06:36Z 2278 followers, XX engagements
"Daiichi Sankyo and MSD Report the P-II Study Data for Raludotatug Deruxtecan in Pt.-Resistant Ovarian Cancer #daiichisankyo #merckco #raludotatugderuxtecan #rdxd #ovariancancer #cdh6 #adc #rejoiceovarian01 #btd #esmo2025 #mk3475"
X Link @Pharmashot 2025-10-21T07:33Z 2278 followers, XXX engagements
/creator/twitter::Pharmashot